236 related articles for article (PubMed ID: 29938473)
21. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals.
Ladabaum U; Mannalithara A; Jandorf L; Itzkowitz SH
Cancer; 2015 Apr; 121(7):1088-97. PubMed ID: 25492455
[TBL] [Abstract][Full Text] [Related]
23. Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.
Cenin DR; Naber SK; de Weerdt AC; Jenkins MA; Preen DB; Ee HC; O'Leary PC; Lansdorp-Vogelaar I
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):10-21. PubMed ID: 31748260
[TBL] [Abstract][Full Text] [Related]
24. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
[TBL] [Abstract][Full Text] [Related]
25. [Acceptance and willingness-to-pay for colorectal colonoscopy screening among high-risk populations for colorectal cancer in urban China].
Shi J; Huang H; Guo L; Ren J; Ren Y; Lan L; Zhou Q; Mao A; Qi X; Liao X; Liu G; Bai Y; Cao R; Liu Y; Wang Y; Gong J; Li N; Zhang K; He J; Dai M;
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 May; 49(5):381-6. PubMed ID: 26081699
[TBL] [Abstract][Full Text] [Related]
26. Pioneering Annual Colorectal Cancer Screening and Treatment Targeting Low Income Communities in Malaysia (20102015).
Tze CN; Fitzgerald H; Qureshi A; Tan HJ; Low ML
Asian Pac J Cancer Prev; 2016; 17(7):3179-83. PubMed ID: 27509948
[TBL] [Abstract][Full Text] [Related]
27. Colorectal Cancer Screening in a Nationwide High-deductible Health Plan Before and After the Affordable Care Act.
Wharam JF; Zhang F; Landon BE; LeCates R; Soumerai S; Ross-Degnan D
Med Care; 2016 May; 54(5):466-73. PubMed ID: 27078821
[TBL] [Abstract][Full Text] [Related]
28. Fecal immunochemical test accuracy in familial risk colorectal cancer screening.
Castro I; Cubiella J; Rivera C; González-Mao C; Vega P; Soto S; Hernandez V; Iglesias F; Teresa Alves M; Bujanda L; Fernández-Seara J
Int J Cancer; 2014 Jan; 134(2):367-75. PubMed ID: 23818169
[TBL] [Abstract][Full Text] [Related]
29. Willingness to Pay for Colorectal Cancer Screening in Vietnam: Policy Implications From a Contingent Valuation Survey.
Nguyen HT; Nguyen AQ
Value Health Reg Issues; 2023 Nov; 38():29-37. PubMed ID: 37441860
[TBL] [Abstract][Full Text] [Related]
30. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
[TBL] [Abstract][Full Text] [Related]
31. Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population.
Fendrick AM; Lieberman D; Vahdat V; Chen JV; Ozbay AB; Limburg PJ
Cancer Prev Res (Phila); 2022 Oct; 15(10):653-660. PubMed ID: 35768200
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
Ladabaum U; Allen J; Wandell M; Ramsey S
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
[TBL] [Abstract][Full Text] [Related]
33. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
[TBL] [Abstract][Full Text] [Related]
34. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.
Subramanian S; Tangka FKL; Hoover S; Royalty J; DeGroff A; Joseph D
Eval Program Plann; 2017 Jun; 62():73-80. PubMed ID: 28190597
[TBL] [Abstract][Full Text] [Related]
35. Balancing Adherence and Expense: The Cost-Effectiveness of Two-Sample vs One-Sample Fecal Immunochemical Test.
Smith DH; O'Keeffe Rosetti M; Mosen DM; Rosales AG; Keast E; Perrin N; Feldstein AC; Levin TR; Liles EG
Popul Health Manag; 2019 Feb; 22(1):83-89. PubMed ID: 29927702
[TBL] [Abstract][Full Text] [Related]
36. Colorectal Cancer Screening in the Era of the Affordable Care Act.
Richman I; Asch SM; Bhattacharya J; Owens DK
J Gen Intern Med; 2016 Mar; 31(3):315-20. PubMed ID: 26349953
[TBL] [Abstract][Full Text] [Related]
37. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
[TBL] [Abstract][Full Text] [Related]
38. Willingness to pay for colorectal cancer screening in Guangzhou.
Zhou Q; Li Y; Liu HZ; Liang YR; Lin GZ
World J Gastroenterol; 2018 Nov; 24(41):4708-4715. PubMed ID: 30416318
[TBL] [Abstract][Full Text] [Related]
39. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
40. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.
McNamara D; Leen R; Seng-Lee C; Shearer N; Crotty P; Neary P; Walsh P; Boran G; O'Morain C
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1415-21. PubMed ID: 25244415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
